coagulation

(redirected from Coagulation system)
Also found in: Thesaurus, Medical, Legal, Encyclopedia.
Related to Coagulation system: Coagulation factors, Coagulation cascade

co·ag·u·late

 (kō-ăg′yə-lāt′)
v. co·ag·u·lat·ed, co·ag·u·lat·ing, co·ag·u·lates
v.tr.
To cause transformation of (a liquid or sol, for example) into or as if into a soft, semisolid, or solid mass.
v.intr.
To become coagulated: As it cooled, the sauce began to coagulate.

[Middle English coagulaten, from Latin coāgulāre, coāgulāt-, from coāgulum, coagulator; see coagulum.]

co·ag′u·la·bil′i·ty n.
co·ag′u·la·ble, co·ag′u·la′tive (-lā′tĭv, -lə-tĭv) adj.
co·ag′u·la′tion n.
co·ag′u·la′tor n.

coagulation

1. The grouping together of small particles in a solution into larger particles. Such a solution eventually coagulates with the particles forming either a precipitate or a gel.
2. blood clotting
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.coagulation - the process of forming semisolid lumps in a liquid
blood clotting, blood coagulation - a process in which liquid blood is changed into a semisolid mass (a blood clot)
natural action, natural process, action, activity - a process existing in or produced by nature (rather than by the intent of human beings); "the action of natural forces"; "volcanic activity"
thermocoagulation - congealing tissue by heat (as by electric current)
Translations

coagulation

[kəʊˌægjʊˈleɪʃən] Ncoagulación f

coagulation

[kəʊˌægjʊˈleɪʃən] ncoagulation f

coagulation

n (of blood)Gerinnen nt, → Gerinnung f, → Koagulation f (spec); (of milk)Dickwerden nt; (of jelly)Festwerden nt; (of paint)Eindicken nt

coagulation

[kəʊˌægjʊˈleɪʃn] ncoagulazione f

co·ag·u·la·tion

n. coagulación, coágulo; cambio en la sangre de estado líquido a solido;
disseminated intravascular ______ intravascular diseminada;
___ factorfactor de ___.

coagulation

n coagulación f; disseminated intravascular — (DIC) coagulación intravascular diseminada
References in periodicals archive ?
Continuous active state of coagulation system in patients with nonthrombotic inflammatory bowel disease.
Anticoagulant mechanisms regulate the coagulation system to ensure formation of a clot that is proportional to the injury.
Laboratory tests reveal leukocytosis, thrombocytopenia, and disturbances in the coagulation system, such as the consumption of clotting factors.
Proenzymes characteristically existing as inactive in the intravascular space along with cofactors, cations, and cell-associated phospholipids comprise the coagulation system.
During excessive or pathological fibrinolysis, plasmin breaks down the fibrin meshwork and releases a number of soluble fibrin degradation products (FDPs), which interfere with the coagulation system, inhibit the platelet function and compete with thrombin, and slow down the clot formation by preventing the conversion of fibrinogen to fibrin; all contributing to bleeding tendency8.
Sepsis is a systemic inflammatory response to infection, which includes activation of leukocytes, the release of cytokines and chemokines, the activation of the coagulation system and activation of endothelial cells.
Activation of Human Coagulation System by Liver Derived Clotting Factors of Banna Minipig Inbred Line.
The last quarter of the XX century presented the data of biological rhythms of coagulation system functioning.
Tests used for routine evaluation of the coagulation system are activated partial thromboplastin time (APTT) and international normalized ratio (INR).
Specialists in nanomedicine, nanotechnology, and translational bio-nanotechnology in academia, government, industry, consulting organizations, and regulatory agencies in the US, Europe, Australia, and India address topics such as nanoparticle interaction with erythrocytes, endothelial cells, various types of antigen-presenting cells, complement activation, platelets and the plasma coagulation system, bone marrow cells, nanoparticle use for drug delivery and vaccine adjuvants, sterility and sterilization, the presence of surface contaminants, regulatory considerations for the screening of nanoparticle toxicity to the immune system, the use of animal models to study nanoparticle immunotoxicity, and material characterization.
The rate at which clots resolve depends on the patient s blood coagulation system.